Artificial intelligence (AI) could be around twice as accurate as a biopsy at grading the aggressiveness of some sarcomas, according to new research from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.

Scientists have unveiled the first and largest encyclopaedia of protein alterations in soft tissue sarcomas – opening the door to a new era of understanding and treatment for this group of rare cancers.

Researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, working alongside collaborators from around the globe, are set to begin work on the world’s largest digital hub of sarcoma clinical and research data after receiving a £2.5m grant.